Biotech Valuation Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation

CRSP 52.20

-5.5%

Nov 12 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Icebrg who wrote (5367)	1/9/2002 11:29:10 AM
From: Ian@SI	Read Replies (2) of 52153

IMCL valuation: Seems to me that the latest gem will guarantee that the class action piranhas come out of the woodwork. Whole story for subscribers at: interactive.wsj.com ImClone Shares Sold Prior to FDA's Move ImClone Systems' chief operating officer disposed of a $50 million stake in the biopharmaceuticals developer just weeks before it disclosed the FDA's rejection of its application to sell Erbitux, a colorectal-cancer drug.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next